Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Hair analysis can help diagnose adrenal disorders non-invasively.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

The document concludes that skin grafts are essential for repairing tissue loss, with various types available and ongoing research into substitutes to improve outcomes and reduce donor site issues.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

First-time mothers had higher stress hormone levels in late pregnancy than mothers who had given birth before.

Unable to summarize document.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Androgenetic Alopecia is commonly known as male or female pattern baldness.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Skin symptoms can indicate endocrine disorders and have various treatments.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Ruxolitinib treatment may cause eyelash growth.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.